Lilly(Eli) & Company

NYSE: LLY
$768.35
-$10.27 (-1.3%)
Real Time Data Delayed 15 Min.

LLY Stock Chart and Intraday Price

LLY Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 743,142.26M USD
Shares Outstanding 950,164,000
Eli Lilly and Company is a global leader in pharmaceuticals, focusing on discovering, developing, and marketing a wide range of human medications. With a rich history dating back to 1876 and headquartered in Indianapolis, Indiana, it offers treatments for diabetes, including a comprehensive lineup of insulin products, and type 2 diabetes medications like Jardiance and Trulicity. The company also has a strong presence in oncology, rheumatoid arthritis, dermatology, mental health, and more, with notable products such as Alimta for cancer and Cymbalta for depression. Eli Lilly collaborates with various industry partners to enhance its product offerings.

LLY Articles

The incredible returns equity investors have seen in 2024, and over the past couple months for that matter, have been incredible. This period of time really reminds me of the post-pandemic rally we...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 488.46% and currently trading at $778.00. The company has been around since 1876 and the...
The Dow Jones is one of Wall Street’s most iconic benchmarks and it tracks 30 of America’s largest companies. It was made over 128 years ago but is still relevant and a crucial barometer of the...
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
A stock split divides existing shares into multiple new ones, increasing a given company’s share count and making shares more affordable for those looking to buy in. For the same $10,000...
It’s no surprise that inflation over the past four years have sent the prices of goods and services steeply spiraling upwards.  With certain food staples rising over 40-50%, gas and electricity...
There is a reason the Schwab US Dividend ETF (NYSEARCA:SCHD) is a top-of-list purchase for investors. It provides one of the easiest ways to buy the biggest dividend growth stocks in the U.S....
In the ever-changing world of investing, ETFs have become the go-to choice for many novice and seasoned investors. ETFs are “baskets” of stocks. When you buy an ETF, you’re investing in all the...
Selecting stocks for the long haul can be a challenge. Here is what could be the best-performing stock in 2030 and why.
The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we need it, to everyday pain remediation or allergy medications, big pharma...
Diversification is key in today’s investing world. Exchange-traded funds, or ETFs, offer a convenient and affordable way to achieve this. Think of them as baskets filled with a variety of stocks....
247 Wall St. Key Insights QQQ offers higher growth potential but comes with greater risk due to its reliance on tech stocks. VOO provides broad market exposure with lower risk and steady growth. ...
Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which I’m going to dive into with a few of these picks. Whether we’re...
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Jim Cramer is probably the closest thing we have to stock market superstar influencer. The host of CNBC’s “Mad Money” show is entertaining and popular with a broad swath of investors who like...